PersonExecutiveOperator
Marguerite Hutchinson
Marguerite Hutchinson, J.D., is the Chief Business Officer of STORM Therapeutics, a Cambridge, UK clinical-stage biotech advancing the first RNA methyltransferase inhibitor into clinical development. A Harvard graduate and lawyer by training, she has spent more than a decade turning early science into deals - building licensing partnerships with Roche, Merck, AstraZeneca, AbbVie and Cancer Research UK, founding and funding a UCSF spin-out, and steering a first-in-class cancer drug through to approval. She was named one of the Top 25 Women Leaders in Biotechnology.
biotechchief business officerrna epigeneticsstorm therapeuticsoncologydrug discovery
